About 100 reports

  • SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)

Spinal cord stimulation involves the implantation of an implanted pulse generator (IPG) in the spinal cord to provide pain relief.

  • Neurological Disorder
  • Abbott Laboratories, Inc.
  • AxoGen, Inc.
  • Boston Scientific Corporation
  • Medtronic, Inc.

Quell is available as over the counter for chronic pain relief.

  • Neurological Disorder
  • Urology Device
  • World
  • Market Size
  • Boston Scientific Corporation
  • HIGH INCIDENCE RATES OF BRAIN ANEURYSM AND CEREBRAL DISORDERS

Currently, SCS systems are used for pain relief, but in the future, they will be also used to treat angina and asthma.

  • Neurological Disorder
  • World
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Stryker Corporation
  • 7.2.2 BOSTON SCIENTIFIC - NEUROMODULATION PRODUCTS PORTFOLIO
  • 7.3.2 ST. JUDE MEDICAL - NEUROMODULATION PRODUCTS PORTFOLIO

No longer compromise Pain Relief for Full-Body MRI - Precision Montage MRI couples the most advanced programming proven to provide excellent pain relief and Full-Body MRI. ##.

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • DATE

Medtronic pioneered the neuromodulation device market by getting FDA approval for pain relief as early as 1984.

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.

In March 2015, Medtronic launched a nationwide pain relief campaign in Kuwait.

  • Neurological Disorder
  • Market Size
  • Flowonix Medical, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated

Global pacemaker electrodes market 2016-2021 ($ millions) Global pacemaker electrodes market: Year-over-year growth 2017-2021 (%) TENS electrodes TENS is used in pain relief therapies.

  • Medical Equipment
  • Neurological Disorder
  • World
  • Forecast
  • Medtronic, Inc.

pain relief solutions KEY HIGHLIGHTS PART ##: Appendix List of abbreviations MEG magnetoencephalography polysomnography PSG PART ##: Explore Technavio Our team of ## specialized market research analysts continuously monitor and evaluate the global market landscape.

  • Neurological Disorder
  • Neurological Monitoring
  • Compumedics Limited
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • INCREASING RESEARCH STUDIES ON ELECTRICAL STIMULATION

THE DEVICE INHIBITS THE PAIN SIGNALS BEFORE THEY REACH THE BRAIN, THUS LEADING TO INDIVIDUALS EXPERIENCING PAIN RELIEF.

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • INCREASING FOCUS ON RESEARCH

These initiatives enable the efforts to increase awareness among various stakeholders regarding the growing disease burden as well as the technological advances for rapid muscular and pain relief.

  • Neurological Disorder
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Sonova Holding AG

IT OFFERS PAIN RELIEF AND ANTI-INFLAMMATORY PROPERTIES.

  • Neurological Disorder
  • Allergan plc
  • Ipsen S.A.
  • Pfizer Inc.
  • Teva Pharmaceuticals Ltd.
  • SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • KEY FINDINGS

This release enabled the company to provide pain relief to a broader spectrum of patients suffering from chronic pain.

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.

The pain relief induced by analgesics occurs either by blocking pain signals going to the brain or by interfering with the brain' s interpretation of the signals, without producing anesthesia or loss of consciousness.

  • Neurological Disorder
  • United States
  • Auspex Pharmaceuticals, Inc.
  • Cephalon, Inc.
  • ChemGenex Pharmaceuticals Limited
  • CHRONIC SHOULDER PAIN

UNLIKE OTHER NEUROSTIMULATION TECHNOLOGIES, THE SMARTPATCH IS DESIGNED TO OFFER LASTING PAIN RELIEF EVEN AFTER THE SHORT-TERM THERAPY HAS ENDED.

  • Neurological Disorder
  • United States
  • Bioness Inc.
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • Grunenthal GmbH
  • was registered with the U.S. National Institutes of Health.
  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • MediciNova, Inc.

THE INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES AND TARGETED PAIN RELIEF, COUPLED WITH THE LIMITED SIDEEFFECTS AND COST-EFFECTIVE PAIN RELIEF OFFERED BY NEUROSTIMULATORS ARE DRIVING THE GROWTH OF THIS MARKET SEGMENT.

  • Cardiac Management
  • Medical Device
  • Neurological Disorder
  • World
  • Market Size
  • METACHROMATIC LEUKODYSTROPHY (MLD) - PIPELINE BY ARMAGEN INC, H1 2017
  • METACHROMATIC LEUKODYSTROPHY (MLD) - PIPELINE BY GLAXOSMITHKLINE PLC, H1 2017

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • ArmaGen
  • SEP 08, 2016: VIROMED PROCEEDING WITH THE WORLD'S FIRST PHASE III GENE THERAPY CLINICAL TRIAL FOR DIABETIC PERIPHERAL NEUROPATHY

Current treatment options of diabetic peripheral neuropathy mainly focus on pain relief such as glucose level control and pain management.

  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • ViroMed Co., Ltd.
  • Target
  • Health Services
  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative
  • METACHROMATIC LEUKODYSTROPHY (MLD) - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2016

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Mental Health
  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • Allergan plc
  • Clinical Trial profile. 29 Trial Title
  • Clinical Trial Profile Snapshots

Pain Relief in Patients with Chronic Pain from Complex Regional Pain Syndrome Type ## (CRPSARA) GDCT## EudraCT-2012-##-##, P##.

  • Mental Health
  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative

Preclinical study confirmed that RPI-##M had analgesic activity and supports some of the clinical reports of pain relief in subjects with herpes infections and rheumatoid arthritis.

  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • Viking Therapeutics, Inc.
  • Diabetic Peripheral Neuropathy - Product Development Milestones

Current treatment options of diabetic peripheral neuropathy mainly focus on pain relief such as glucose level control and pain management.

  • Neurological Disorder
  • Pathology
  • United States
  • Product Initiative
  • ViroMed Co., Ltd.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Pain Relief in Patients with Chronic Pain from Complex Regional Pain Syndrome Type ## (CRPSARA) GDCT## EudraCT-2012-##-##, P##.

  • Drug Discovery And Development
  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Neurological Disorder
  • Neurology
  • United States
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Pain Relief After Carpal Tunnel Release Surgery Patient Satisfaction with Pain Relief After Ambulatory Hand Surgery GDCT## NCT##, 2011P## Central Nervous System Carpal Tunnel Syndrome, Post-Operative Pain Terminated Phase IV Interventional (acetaminophen + hydrocodon

  • Health Services
  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and GLAXOSMITHKLINE PLC respiratory diseases.

  • Dementia
  • Neurological Disorder
  • United States
  • Product Initiative
  • Oryzon Genomics S.A.

CB## agonists are ##, ## times more selective for the CB## receptor than the CB##, and thereby result in pain relief without psychotropic and other side effects seen with less selective agonists.

  • Chronic Pain
  • Clinical Trial
  • Neurological Disorder
  • Pharmaceutical
  • Eli Lilly & Co.